short interest very high,, page-4

The large number of shorts indicates that many expect a big drop in share price. I wonder if there will be other positive news to counteract that expectation. We got early ape study news, but of course, there could be more news from the same study ( alpha-synuclein, neurofilament light, microscopy findings, bigger numbers of apes, perhaps something about eyes, etc).

Biomarker study in the MSA population is still recruiting but there are today several patients who have taken ATH434 for some 6 months and many more who have taken it 4 months. In the apes, changes were noticed in 12 weeks. So it could be possible to get early biomarker study results much sooner than next summer. In a slide, presented by Stamler, there was a hint that some info would come in March, but he said that info would come only in the summer. Usually, new results are presented at some congress. Sure, there are also other possibilities. The AAN meeting starts on the 13th of April, that has been the normal meeting for ATH but it is quite late to have any effect on the possible drop of SP in January.

Then they have these negotiations or only talks with Big Pharma, as was told by Stamler. In these ATH can present much more inside info when negotiating cooperation. ATH will not be marketing their products, they need a partner. These announcements are usually big surprises, and we have been waiting for them some over 10 years. Now, however, any moment is possible with these ape and biomarker studies.